Skip to main content
Top
Published in: Journal of Cancer Education 4/2021

01-08-2021 | Human Papillomavirus

A Study on Knowledge and Awareness of Cervical Cancer Among Females of Rural and Urban Areas of Haryana, North India

Authors: Lokesh Kadian, Gulshan Gulshan, Shivkant Sharma, Indu Kumari, Chetna Yadav, Smiti Nanda, Ritu Yadav

Published in: Journal of Cancer Education | Issue 4/2021

Login to get access

Abstract

Lack of awareness of screening methods, risk factors, and symptoms may lead to late diagnosis and poor prognosis of cervical cancer. The plan of this study was to assess the level of awareness about cervical cancer and HPV vaccine among females of rural and urban areas of Haryana, India. This cross-sectional study was performed using a comprehensive self-designed questionnaire on 1500 women of urban (700) and rural (800) background aged 18–65 years, evaluating their knowledge for cervical cancer and screening, HPV infection and its preventive measure, and symptoms and risk factors. Data obtained was analyzed and interpreted by using simple percentages and bar charts. Most of the participants were aged between 21 and 30 years and had college level education. Majority of the women from rural areas had poor knowledge about cervical cancer (55%) and its screening (75%), HPV infection (87.5%), and HPV vaccine (95%) compared with urban areas. Knowledge about symptoms and risk factors was very low in both rural and urban areas. Whatever little knowledge the women had about cervical cancer was from college education, friends, neighbors, relatives, and medical practitioner or doctors. The survey pointed to the critical need to educate women about cervical cancer and its early diagnosis, related risk factors, symptoms, and preventive measures which can be achieved by launching extensive awareness programs for educating females about cervical cancer in India.
Literature
7.
go back to reference Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A, Galazios G (2016) Cervical cancer: screening, diagnosis and staging. J BUON 21:320–325PubMed Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A, Galazios G (2016) Cervical cancer: screening, diagnosis and staging. J BUON 21:320–325PubMed
10.
go back to reference Institute for Health Metrics and Evaluation (2011) The challenge ahead: progress and setbacks in breast and cervical cancer. IHME, Seattle Institute for Health Metrics and Evaluation (2011) The challenge ahead: progress and setbacks in breast and cervical cancer. IHME, Seattle
11.
go back to reference Arunadevi V, Prasad G (2015) Knowledge and awareness of cervical cancer among women in rural India. Int J Cur Res Rev 7(21):29 Arunadevi V, Prasad G (2015) Knowledge and awareness of cervical cancer among women in rural India. Int J Cur Res Rev 7(21):29
17.
go back to reference Chatterjee S, Chattopadhyay A, Samanta L, Panigrahi P (2016) HPV and cervical cancer epidemiology - current status of HPV vaccination in India. Asian Pac J Cancer Prev 17:3663–3673PubMed Chatterjee S, Chattopadhyay A, Samanta L, Panigrahi P (2016) HPV and cervical cancer epidemiology - current status of HPV vaccination in India. Asian Pac J Cancer Prev 17:3663–3673PubMed
Metadata
Title
A Study on Knowledge and Awareness of Cervical Cancer Among Females of Rural and Urban Areas of Haryana, North India
Authors
Lokesh Kadian
Gulshan Gulshan
Shivkant Sharma
Indu Kumari
Chetna Yadav
Smiti Nanda
Ritu Yadav
Publication date
01-08-2021
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2021
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01712-6

Other articles of this Issue 4/2021

Journal of Cancer Education 4/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine